A new scoring tool that helps to ‘transparently’ prioritize which countries are in greatest need of Covid-19 vaccines, has been developed by a UCL-led team of researchers.

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy.

A new study, led by researchers at NYU Grossman School of Medicine and NYU Long Island School of Medicine, shows that two kidney transplant patients treated with immunosuppressive drugs, and who later had a lengthy COVID-19 infection, developed a version of the virus with a genetic change (mutation) that made it resistant to the antiviral therapy remdesivir.

This rise was due to new entrepreneurs going ahead with their start-up plans that had been postponed during 2020 There was a sharp rise in the number of women setting up new businesses in 2021 while the number of older age entrepreneurs doubled.

Children who were infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study that analyzed electronic health records of more than 1 million patients ages 18 and younger.

A Providence study released online today in the Journal of the American Medical Association sheds new light on the added benefit of a booster dose of a COVID-19 mRNA vaccine among previously vaccinated individuals.

About The Study: In a large U.S. population, COVID-19 mRNA boosters were associated with decreased odds of hospitalization compared with the mRNA vaccine primary series alone, with the magnitude of the association reduced with more time since the booster dose.

About The Study: New type 1 diabetes diagnoses were more likely to occur among pediatric patients with prior COVID-19 than among those with other respiratory infections in this study, but researchers acknowledge study limitations that include the observational and retrospective design of the electronic health record analysis and the possibility that additional unidentified factors accounted for the association.

About The Study: In 348 California hospitals, hospital financial performance was highly variable during the COVID-19 pandemic. Losses were reduced by COVID-19 relief funding and strong equities market performance starting in the second quarter of 2020. Non–safety net hospitals maintained positive operating margins throughout the pandemic, while safety-net hospitals experienced large losses. Between the first quarter of 2020 and the second quarter of 2021, California safety-net hospitals’ net operating losses were more than $3.2 billion.

Cooperation among many disciplines is required to improve the health situation and equity of all people worldwide. At its two-day Annual Assembly 2022, which will begin today in Halle (Saale)/Germany, the German National Academy of Sciences Leopoldina addresses "Global Health: From Health Services to Climate Change and to Social Justice" and thus focuses on a broad spectrum of global health issues. In the morning, WHO Director General Dr. Tedros Adhanom Ghebreyesus, German Federal Minister of Education and Research Bettina Stark-Watzinger, and Minister President of Saxony-Anhalt Dr. Reiner Haseloff will all give welcome addresses. The Annual Assembly lectures are all being livestreamed.

A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports fourth vaccination for this vulnerable group. However, passive immunisation by administering an antibody combination to cancer patients does not seem to provide adequate protection. The study has now been published in the top journal "JAMA Oncology".